Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
GLP-1 drugs (Ozempic, Mounjaro, Trulicity) are popular treatments for diabetes type 2, weight loss Trulicity, Mounjaro, and Ozempic are all part of a class of medications called glucagon-like peptide-1 (GLP-1) and dual GLP-1/GIP (glucose-dependent insulintropic polypeptide) receptor agonists, which are used to type 2 diabetes and, with respect to certain drugs, for chronic weight management
GLP-1s role as an insulinotropic incretin remained undetermined until GLP-1 (7-37), a truncated form of GLP-1, was identified by Mojsov et al
The Merck Manual of Geriatrics
Medicare patients will have a $50 co-pay for the drugs and could see the new pricing as soon as mid-2026
Research demonstrates that GLP-1 receptor agonists such as semaglutide can reduce systolic blood pressure by 3-5 mmHg on average, with greater improvements observed in patients who achieve significant weight loss
Your doctor will review your medical history to make sure its safe for you
US$ 28.73
US$ 23.57
US$ 26.10
